PGEN - PRECIGEN, INC.
IEX Last Trade
0.7408
0.013 1.795%
Share volume: 8,981
Last Updated: Fri 27 Dec 2024 08:30:20 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$0.73
0.01
1.83%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-09 | 2023-03-06 | 2023-05-10 | 2023-08-09 | 2023-11-09 | 2024-03-19 | 2024-05-14 | |
| Assets | |||||||||
| Total Assets | 321.224 M | 259.245 M | 215.977 M | 241.546 M | 207.527 M | 190.688 M | 151.043 M | 134.847 M | |
| Current Assets | 164.619 M | 162.806 M | 118.159 M | 137.743 M | 105.632 M | 92.988 M | 68.755 M | 49.546 M | |
| Inventories | 224.000 K | 219.000 K | 287.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 2.654 M | 6.363 M | 4.779 M | 4.330 M | 2.792 M | 5.128 M | 4.325 M | 3.626 M | |
| Short Term Investments | 2.654 M | 6.363 M | 4.779 M | 4.330 M | 2.792 M | 5.128 M | 4.325 M | 3.626 M | |
| Total Receivables | 1.871 M | 2.454 M | 13.804 M | 15.522 M | 14.406 M | 14.105 M | 1.575 M | 1.162 M | |
| Current Cash | 115.297 M | 71.327 M | 55.950 M | 104.091 M | 88.434 M | 73.755 M | 62.855 M | 44.758 M | |
| Total Non-current Assets | 156.605 M | 96.439 M | 97.818 M | 103.803 M | 101.895 M | 97.700 M | 82.288 M | 85.301 M | |
| Property Plant Equipment | 7.726 M | 7.611 M | 7.329 M | 6.908 M | 6.574 M | 7.115 M | 7.111 M | 12.620 M | |
| Other Assets | 45.261 M | 871.000 K | 1.025 M | 1.004 M | 949.000 K | 797.000 K | 767.000 K | 751.000 K | |
| Intangible Assets | 45.933 M | 42.416 M | 44.455 M | 43.848 M | 42.656 M | 40.426 M | 40.701 M | 38.717 M | |
| Goodwill | 36.864 M | 36.713 M | 36.923 M | 36.966 M | 36.966 M | 36.894 M | 26.612 M | 26.555 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 321.224 M | 259.245 M | 215.977 M | 241.546 M | 207.527 M | 190.688 M | 151.043 M | 134.847 M | |
| Total liabilities | 265.571 M | 116.713 M | 89.718 M | 57.413 M | 41.317 M | 43.010 M | 32.545 M | 37.828 M | |
| Total current liabilities | 29.901 M | 104.864 M | 78.645 M | 46.733 M | 30.773 M | 32.875 M | 22.985 M | 28.774 M | |
| Accounts Payable | 2.668 M | 4.201 M | 4.068 M | 3.809 M | 2.510 M | 2.351 M | 1.726 M | 4.716 M | |
| Other liabilities | 26.638 M | 1.818 M | 1.818 M | 1.818 M | 1.818 M | 1.818 M | 1.818 M | 1.888 M | |
| Current long term debt | 0.000 | 82.069 M | 43.219 M | 13.819 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 198.674 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 26.638 M | 1.818 M | 1.818 M | 1.818 M | 1.818 M | 1.818 M | 1.818 M | 1.888 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 55.653 M | 142.532 M | 126.259 M | 184.133 M | 166.210 M | 147.678 M | 118.498 M | 97.019 M | |
| Common stock | 200.461 M | 200.671 M | 200.682 M | 229.770 M | 248.003 M | 248.521 M | 251.850 M | 249.220 M | |
| Retained earnings | -1.934 B | -1.846 B | -1.869 B | -1.891 B | -1.912 B | -1.931 B | -1.964 B | -1.988 B |